We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:
QIAGEN and Applied Biosystems have announced a settlement of their disputes concerning infringement by Corbett’s Rotor-Gene™ Real-Time PCR-Cyclers and Applied Biosystems’ Real-Time Thermal Cycler Instrument patents.

Applied Biosystems had filed an infringement lawsuit against Corbett in Germany and Corbett later filed a declaratory judgment lawsuit in California. Further, Corbett and ltf Labortechnik filed an intervention in opposition proceedings before the European Patent Office. QIAGEN acquired Corbett, an Australian instrumentation manufacturing company, in July 2008.

In connection with the settlement, Corbett has entered into an agreement with Applied Biosystems to take a license to certain technology relating to Corbett’s Real-Time PCR-Instrumentation and its use. The license covers all fields including research-related fields, applied fields and the fields of human and animal in vitro diagnostics.

Financial terms of the settlement and related license agreement were not disclosed. These agreements fully resolve all pending disputes between Corbett, QIAGEN, ltf Labortechnik, and Applied Biosystems.